| Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group | Journal of Clinical Oncology | 2001 | 860 |
| Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells | Journal of Cell Biology | 1982 | 568 |
| Inducible secretion of large, biologically potent von Willebrand factor multimers | Cell | 1986 | 389 |
| Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System | Cancer | 2008 | 386 |
| Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates | Circulation | 2012 | 322 |
| Role of tissue factor in cancer | Journal of Clinical Oncology | 2009 | 285 |
| Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors | American Journal of Hematology | 2012 | 280 |
| Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization | Journal of Cell Biology | 1984 | 262 |
| Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis | Haematologica | 2018 | 219 |
| Dysregulated gene expression networks in human acute myelogenous leukemia stem cells | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 219 |
| Patient-centered care and breast cancer survivors' satisfaction with information | Patient Education and Counseling | 2005 | 207 |
| Undertreatment of obese women receiving breast cancer chemotherapy | Archives of Internal Medicine | 2005 | 202 |
| Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways | Transplantation | 2005 | 191 |
| Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial | JAMA Oncology | 2019 | 190 |
| Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo | FASEB Journal | 1989 | 189 |
| Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms | Journal of Clinical Oncology | 1990 | 172 |
| Impact of venous thromboembolism and anticoagulation on cancer and cancer survival | Journal of Clinical Oncology | 2009 | 170 |
| International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders | Lancet Oncology, The | 2019 | 166 |
| Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation | Nature Medicine | 2007 | 164 |
| The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring | Annals of Internal Medicine | 1979 | 153 |
| Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2) | Journal of Thrombosis and Haemostasis | 2008 | 146 |
| Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy | Breast Cancer Research and Treatment | 2003 | 143 |
| Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors | Nature | 2008 | 132 |
| The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation | Nature | 2014 | 129 |
| Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor | Journal of Cell Biology | 1986 | 128 |
